168 related articles for article (PubMed ID: 22112046)
1. Emerging drugs for diabetic retinopathy.
Pipis A; Scholl S; Augustin AJ
Expert Opin Emerg Drugs; 2011 Dec; 16(4):669-81. PubMed ID: 22112046
[TBL] [Abstract][Full Text] [Related]
2. Upcoming therapeutic advances in diabetic macular edema: an intravitreal dexamethasone drug delivery system.
Augustin AJ
Expert Opin Drug Deliv; 2011 Feb; 8(2):271-9. PubMed ID: 21222552
[TBL] [Abstract][Full Text] [Related]
3. Current and investigational drugs for the treatment of diabetic retinopathy.
Tolentino MS; Tolentino AJ; Tolentino MJ
Expert Opin Investig Drugs; 2016 Sep; 25(9):1011-22. PubMed ID: 27367620
[TBL] [Abstract][Full Text] [Related]
4. Update on treatments for diabetic macular edema.
Fraser-Bell S; Kaines A; Hykin PG
Curr Opin Ophthalmol; 2008 May; 19(3):185-9. PubMed ID: 18408491
[TBL] [Abstract][Full Text] [Related]
5. [Fluocinolone acetonide (ILUVIEN®) micro-implant for chronic diabetic macular edema].
Soubrane G; Behar-Cohen F
J Fr Ophtalmol; 2015 Feb; 38(2):159-67. PubMed ID: 25601517
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic stratagems for vascular degenerative disorders of the posterior eye.
Jain GK; Warsi MH; Nirmal J; Garg V; Pathan SA; Ahmad FJ; Khar RK
Drug Discov Today; 2012 Jul; 17(13-14):748-59. PubMed ID: 22504325
[TBL] [Abstract][Full Text] [Related]
7. Role of steroids in the management of diabetic macular edema and proliferative diabetic retinopathy.
Silva PS; Sun JK; Aiello LP
Semin Ophthalmol; 2009; 24(2):93-9. PubMed ID: 19373693
[TBL] [Abstract][Full Text] [Related]
8. Intravitreal triamcinolone for diabetic macular edema that persists after laser treatment: three-month efficacy and safety results of a prospective, randomized, double-masked, placebo-controlled clinical trial.
Sutter FK; Simpson JM; Gillies MC
Ophthalmology; 2004 Nov; 111(11):2044-9. PubMed ID: 15522370
[TBL] [Abstract][Full Text] [Related]
9. Intravitreal fluocinolone acetonide implant (ILUVIEN®) for diabetic macular oedema: a literature review.
Massa H; Nagar AM; Vergados A; Dadoukis P; Patra S; Panos GD
J Int Med Res; 2019 Jan; 47(1):31-43. PubMed ID: 30556449
[TBL] [Abstract][Full Text] [Related]
10. Pharmacologic therapy for diabetic retinopathy.
Gardlik R; Fusekova I
Semin Ophthalmol; 2015 Jul; 30(4):252-63. PubMed ID: 24571780
[TBL] [Abstract][Full Text] [Related]
11. Two-year results of a randomized trial of intravitreal bevacizumab alone or combined with triamcinolone versus laser in diabetic macular edema.
Soheilian M; Garfami KH; Ramezani A; Yaseri M; Peyman GA
Retina; 2012 Feb; 32(2):314-21. PubMed ID: 22234244
[TBL] [Abstract][Full Text] [Related]
12. Intravitreal bevacizumab (avastin) injection alone or combined with triamcinolone versus macular photocoagulation as primary treatment of diabetic macular edema.
Soheilian M; Ramezani A; Bijanzadeh B; Yaseri M; Ahmadieh H; Dehghan MH; Azarmina M; Moradian S; Tabatabaei H; Peyman GA
Retina; 2007; 27(9):1187-95. PubMed ID: 18046223
[TBL] [Abstract][Full Text] [Related]
13. [Intravitreal triamcinolone for diabetic macular oedema. Method and complications].
Zamfir C
Oftalmologia; 2009; 53(1):100-5. PubMed ID: 19569613
[TBL] [Abstract][Full Text] [Related]
14. [Pharmacological treatment for diabetic macular edema].
Fukumoto M; Ikeda T
Nihon Rinsho; 2015 Mar; 73(3):484-8. PubMed ID: 25812378
[TBL] [Abstract][Full Text] [Related]
15. Pharmacotherapies for diabetic retinopathy: present and future.
Schwartz SG; Flynn HW
Exp Diabetes Res; 2007; 2007():52487. PubMed ID: 17713597
[TBL] [Abstract][Full Text] [Related]
16. Intravitreal bevacizumab combined with/without triamcinolone acetonide in single injection for treatment of diabetic macular edema.
Wang YS; Li X; Wang HY; Zhang ZF; Li MH; Su XN
Chin Med J (Engl); 2011 Feb; 124(3):352-8. PubMed ID: 21362332
[TBL] [Abstract][Full Text] [Related]
17. Combination therapy in diabetic macular oedema and retinal vein occlusion--past and present.
Koss MJ; Naser H; Sener A; Ackermann H; Al-Sarireh F; Singh P; Koch FH
Acta Ophthalmol; 2012 Sep; 90(6):580-9. PubMed ID: 20636486
[TBL] [Abstract][Full Text] [Related]
18. The therapeutic potential of intraocular depot steroid systems: developments aimed at prolonging duration of efficacy.
Nentwich MM; Ulbig MW
Dtsch Arztebl Int; 2012 Sep; 109(37):584-90. PubMed ID: 23093988
[TBL] [Abstract][Full Text] [Related]
19. Changing paradigms in the treatment of diabetic retinopathy.
El-Asrar AM; Al-Mezaine HS; Ola MS
Curr Opin Ophthalmol; 2009 Nov; 20(6):532-8. PubMed ID: 19644368
[TBL] [Abstract][Full Text] [Related]
20. Long-term benefit of sustained-delivery fluocinolone acetonide vitreous inserts for diabetic macular edema.
Campochiaro PA; Brown DM; Pearson A; Ciulla T; Boyer D; Holz FG; Tolentino M; Gupta A; Duarte L; Madreperla S; Gonder J; Kapik B; Billman K; Kane FE;
Ophthalmology; 2011 Apr; 118(4):626-635.e2. PubMed ID: 21459216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
